Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-10-25FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approves a supplemental application for lurasidone hydrochloride by Heritage Pharma Labs (Avet) under an ANDA, enabling continued or exp…
-
FDA approval · 2021-10-20FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (Zameer Pharmaceuticals LLC)
FDA approved the original ANDA for fluphenazine hydrochloride (generic) manufactured by Zameer Pharmaceuticals LLC.
-
FDA approval · 2021-09-28FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approves Cosette Pharmaceuticals' prochlorperazine edisylate as an original generic application for use as an antiemetic.
-
FDA approval · 2021-08-31FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves a supplemental application for risperidone by Amneal Pharmaceuticals LLC. This action represents a supplemental approval under …
-
FDA approval · 2021-08-30FDA Approved: INVEGA HAFYERA — Supplemental Application (Janssen Pharmaceuticals, Inc)
The FDA approved a supplemental application for Invega Hafyera (paliperidone palmitate) to expand its label for the long-acting injectable t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-08-24FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's original application for lurasidone hydrochloride tablets as a generic treatment for schizoph…
-
FDA approval · 2021-08-23FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Mylan Institutional LLC)
FDA approves a supplemental application for HALOPERIDOL DECANOATE from Mylan Institutional LLC, confirming a generic long-acting injectable …
-
FDA approval · 2021-08-09FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2021-08-09FDA Approved: INVEGA HAFYERA — Supplemental Application (Janssen Pharmaceuticals, Inc)
FDA approved a supplemental application for INVEGA HAFYERA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2021-07-29FDA Approved: CLOZAPINE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for clozapine from Accord Healthcare Inc. (generic clozapine). The approval pertains to a supplement…
-
FDA approval · 2021-07-29FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Clozapine from Mylan Pharmaceuticals Inc.
-
FDA approval · 2021-07-29FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
The FDA approved a supplemental application for Versacloz, a brand of clozapine, submitted by TruPharma LLC.
-
FDA approval · 2021-07-29FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc., authorizing a generic Clozapine product.
-
FDA approval · 2021-07-29FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for CLOZAPINE submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2021-07-29FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics USA, Inc., typically to update labeling.
-
FDA approval · 2021-07-26FDA Approved: HALOPERIDOL DECANOATE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved haloperidol decanoate under an original ANDA from Meitheal Pharmaceuticals as a long-acting injectable antipsychotic indicated …
-
FDA approval · 2021-07-19FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for ziprasidone hydrochloride from Apotex Corp., enabling the marketing of a generic version of the …
-
FDA approval · 2021-07-19FDA Approved: QUETIAPINE EXTENDED-RELEASE — Supplemental Application (AlignScience Pharma Inc.)
FDA approved AlignScience Pharma Inc.'s supplemental application for quetiapine extended-release, enabling its marketing as a generic produc…
-
FDA approval · 2021-06-02FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Sandoz, Inc.)
FDA approved chlorpromazine hydrochloride as a generic drug through an original ANDA submitted by Sandoz, Inc.
-
FDA approval · 2021-05-28FDA Approved: LYBALVI — Original Application (Alkermes, Inc.)
FDA approved LYBALVI (olanzapine and samidorphan L-malate) from Alkermes as an original drug application. It is indicated for the treatment …
-
FDA approval · 2021-05-27FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
The FDA approved the original application for Fluphenazine hydrochloride from Zydus Pharmaceuticals (USA) Inc., enabling marketing as a gene…
-
FDA approval · 2021-05-18FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone mesylate) filed by Viatris Specialty LLC.
-
FDA approval · 2021-05-18FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2021-05-13FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals' generic Lurasidone hydrochloride tablets under an Original Application (ANDA213248). Lurasidone is use…
-
FDA approval · 2021-04-28FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC, resulting in an update to the …